Literature DB >> 17538895

Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

Judith E Epstein1, Suchitra Rao, Frank Williams, Daniel Freilich, Thomas Luke, Martha Sedegah, Patricia de la Vega, John Sacci, Thomas L Richie, Stephen L Hoffman.   

Abstract

BACKGROUND: Challenge of volunteers by the bites of membrane-fed anopheline mosquitoes infected with Plasmodium falciparum was reported in 1986. In 1997, an analysis of experience with 118 volunteers indicated that mosquito inoculation of P. falciparum could be a safe, well-tolerated, reproducible, and efficient method of challenge.
METHODS: We reviewed the records of 47 volunteers challenged at our institution with the NF54 isolate of P. falciparum between 1998 and 2002. We also reviewed data from 17 published studies of experimental challenge conducted since 1996.
RESULTS: At our institution, the time to onset of first symptoms (incubation period) was 8.9 days, and the time to first detectable parasitemia on blood smear (prepatent period) was 10.5 days. All volunteers became symptomatic. Most symptoms were mild to moderate, although 21% of volunteers had at least 1 severe symptom. None developed complicated or severe malaria, and all were cured. Laboratory assessments demonstrated modest, short-term abnormalities typical of malaria. Review of 17 published studies demonstrated that an additional 367 volunteers received experimental challenge safely with similar outcomes.
CONCLUSIONS: In total, data from 532 volunteers demonstrate that experimental challenge is safe and results in predictable incubation and prepatent periods. Our findings support the continued use of this method for testing efficacy of vaccines and drugs against P. falciparum.

Entities:  

Mesh:

Year:  2007        PMID: 17538895     DOI: 10.1086/518510

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  69 in total

1.  Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials.

Authors:  Sean C Murphy; Jennifer L Prentice; Kathryn Williamson; Carolyn K Wallis; Ferric C Fang; Michal Fried; Cris Pinzon; Ruobing Wang; Angela K Talley; Stefan H I Kappe; Patrick E Duffy; Brad T Cookson
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

Review 2.  Systems immunology of human malaria.

Authors:  Tuan M Tran; Babru Samal; Ewen Kirkness; Peter D Crompton
Journal:  Trends Parasitol       Date:  2012-05-15

3.  Ethical Criteria for Human Challenge Studies in Infectious Diseases.

Authors:  Ben Bambery; Michael Selgelid; Charles Weijer; Julian Savulescu; Andrew J Pollard
Journal:  Public Health Ethics       Date:  2015-09-27       Impact factor: 1.940

Review 4.  Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.

Authors:  Jerome P Vanderberg
Journal:  Vaccine       Date:  2008-10-28       Impact factor: 3.641

Review 5.  Immune mechanisms in malaria: new insights in vaccine development.

Authors:  Eleanor M Riley; V Ann Stewart
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

Review 6.  Murine infection models for vaccine development: the malaria example.

Authors:  Kai Matuschewski
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

7.  High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.

Authors:  Sheetij Dutta; JoAnn S Sullivan; Katharine K Grady; J David Haynes; Jack Komisar; Adrian H Batchelor; Lorraine Soisson; Carter L Diggs; D Gray Heppner; David E Lanar; William E Collins; John W Barnwell
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

8.  Plasmodium yoelii-infected A. stephensi inefficiently transmit malaria compared to intravenous route.

Authors:  Solomon Conteh; Rana Chattopadhyay; Charles Anderson; Stephen L Hoffman
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

9.  Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.

Authors:  Adama Tall; Cheikh Sokhna; Ronald Perraut; Didier Fontenille; Laurence Marrama; Alioune B Ly; Fatoumata D Sarr; Aïssatou Toure; Jean-François Trape; André Spiegel; Christophe Rogier; Pierre Druilhe
Journal:  Malar J       Date:  2009-07-15       Impact factor: 2.979

10.  Cardiac complication after experimental human malaria infection: a case report.

Authors:  An-Emmie Nieman; Quirijn de Mast; Meta Roestenberg; Jorien Wiersma; Gheorghe Pop; Anton Stalenhoef; Pierre Druilhe; Robert Sauerwein; André van der Ven
Journal:  Malar J       Date:  2009-12-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.